Exposure to paracetamol and asthma symptoms

European Journal of Public Health

Volumn 23, Issue 4, 2013, Pages 706-710

  Gonzalez Barcala, Francisco Javier ^a   Pertega, Sonia ^b   Castro, Teresa Perez ^c   Sampedro, Manuel ^d   Lastres, Juan Sanchez ^d   Gonzalez, Miguel Angel San Jose ^d   Bamonde, Luis ^d   Garnelo, Luciano ^d   Valdes, Luis ^a   Carreira, Jose M ^a   Moure, Jose ^d   Silvarrey, Angel Lopez ^e  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL JUAN CANALEJO   (Spain)

^c UNIVERSITY OF A CORUÑA   (Spain)

^d Servicio Galego de Saude   (Spain)

^e Maria Jose Jove Foundation   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; PARACETAMOL;

ADOLESCENT; AGE; ANIMAL; ARTICLE; ASTHMA; CAT; CHEMICALLY INDUCED DISORDER; CHILD; CROSS-SECTIONAL STUDY; DOG; EDUCATIONAL STATUS; HUMAN; MALE; MULTICENTER STUDY; PREVALENCE; RISK FACTOR; SMOKING; SPAIN; CHEMICALLY INDUCED; CLINICAL TRIAL; EPIDEMIOLOGY;

ACETAMINOPHEN; ADOLESCENT; AGE FACTORS; ANALGESICS, NON-NARCOTIC; ANIMALS; ASTHMA; CATS; CHILD; CROSS-SECTIONAL STUDIES; DOGS; EDUCATIONAL STATUS; HUMANS; MALE; PREVALENCE; RISK FACTORS; SMOKING; SPAIN;

EID: 84875822995     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/cks061     Document Type: Article

References (34)

1. Asher MI, Montefort S, Björkstén B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006;368:733-43
2. Section on Clinical Pharmacology and Therapeutics, Committee on Drugs, Sullivan JE, Farrar HC. Fever and antipyretic use in children. Pediatrics 2011;127: 580-7
3. Jensen JF, Tønnesen LL, Söderström M, et al. Paracetamol for feverish children: Parental motives and experiences. Scand J Prim Health Care 2010;28:115-20
4. Etminan M, Sadatsafavi M, Jafari S, et al. Acetaminophen use and the risk of asthma in children and adults: A systematic review and metaanalysis. Chest 2009;136: 1316-23
5. Shaheen S, Potts J, Gnatiuc L, et al. The relation between paracetamol use and asthma: A GA2LEN European case-control study. Eur Respir J 2008;32:1231-6
6. Beasley RW, Clayton TO, Crane J, et al. Acetaminophen use and risk of asthma, rhinoconjunctivitis, and eczema in adolescents: International Study of Asthma and Allergies in Childhood Phase Three. Am J Respir Crit Care Med 2011;183:171-8
7. Lowe AJ, Carlin JB, Bennett CM, et al. Paracetamol use in early life and asthma: Prospective birth cohort study. BMJ 2010;341:c4616
8. Bakkeheim E, Mowinckel P, Carlsen KH, et al. Paracetamol in early infancy: The risk of childhood allergy and asthma. Acta Paediatr 2011;100:90-6
9. Garcia-Marcos L, Canflanca IM, Garrido JB, et al. Relationship of asthma and rhinoconjunctivitis with obesity, exercise and Mediterranean diet in Spanish schoolchildren. Thorax 2007;62:503-8
10. Ló pez-Silvarrey Varela A, GonzÄlez Barcala FJ, Paz Esquete JJ, et al. Prevalence of asthma and rhinitis symptoms in A Coruña (Spain). An Pediatr 2007;66:146-53
11. Ellwood P, Asher MI, Beasley R, et al. on behalf of the ISAAC Steering Committee and the ISAAC Phase Three Study Group. ISAAC Phase Three Manual. Auckland, New Zealand: ISAAC International Data Centre, 2000
12. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: International survey. BMJ 2000;320:1240-3
13. Yarnell JW, Stevenson MR, MacMahon J, et al. Smoking, atopy and certain furry pets are major determinants of respiratory symptoms in children: The International Study of Asthma and Allergies in Childhood Study (Ireland). Exp Allergy 2003;33: 96-100
14. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variations in the prevalence of asthma symptoms: The International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J 1998;12:315-335
15. Amberbir A, Medhin G, Alem A, et al. The role of acetaminophen and geohelminth infection on the incidence of wheeze and eczema: A longitudinal birth-cohort study. Am J Respir Crit Care Med 2011;183:165-70
16. Shaheen SO, Newson RB, Ring SM, et al. Prenatal and infant acetaminophen exposure, antioxidant gene polymorphisms, and childhood asthma. J Allergy Clin Immunol 2010;126:1141-8
17. Barr RG, Wentowski CC, Curhan GC, et al. Prospective study of acetaminophen use and newly diagnosed asthma among women. Am J Respir Crit Care Med 2004;169: 836-41
18. Thomsen SF, Kyvik KO, Skadhauge L, et al. Intake of paracetamol and risk of asthma in adults. J Asthma 2008;45:675-6
19. Beasley R, Clayton T, Crane J, et al. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: Analysis from Phase Three of the ISAAC programme. Lancet 2008;372: 1039-48
20. Wang HY, Pizzichini MM, Becker AB, et al. Disparate geographic prevalences of asthma, allergic rhinoconjunctivitis and atopic eczema among adolescents in five Canadian cities. Pediatr Allergy Immunol 2010;21:867-77
21. Lesko SM, Louik C, Vezina RM, Mitchell AA. Asthma morbidity after the short-term use of ibuprofen in children. Pediatrics 2002;109:E20
22. Rebordosa C, Kogevinas M, Sørensen HT, Olsen J. Pre-natal exposure to paracetamol and risk of wheezing and asthma in children: A birth cohort study. Int J Epidemiol 2008;37:583-90
23. Rusconi F, Gagliardi L, Galassi C, et al. Paracetamol and antibiotics in childhood and subsequent development of wheezing/asthma: Association or causatioñ Int J Epidemiol 2011;40:662-7
24. Garcia-Marcos L, Gonzälez-Díaz C, Garvajal-Urueña I, et al. Early exposure to paracetamol or to antibiotics and eczema at school age: Modification by asthma and rhinoconjunctivitis. Pediatr Allergy Immunol 2010;21:1036-42
25. Eneli I, Sadri K, Camargo C Jr, Barr RG. Acetaminophen and the risk of asthma: The epidemiologic and pathophysiologic evidence. Chest 2005;12:604-12
26. Nuttall SL, Khan JN, Thorpe GH, et al. The impact of therapeutic doses of paracetamol on serum total antioxidant capacity. J Clin Pharm Ther 2003;28: 289-94
27. Farquhar H, Stewart A, Mitchell E, et al. The role of paracetamol in the pathogenesis of asthma. Clin Exp Allergy 2010;40:32-41
28. Baudouin SV, Howdle P, O'Grady JG, Webster NR. Acute lung injury in fulminant hepatic failure following paracetamol poisoning. Thorax 1995;50:399-402
29. Koelsch M, Mallak R, Graham GG, et al. Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations. Biochem Pharmacol 2010;79:1156-64
30. Nassini R, Materazzi S, Andrè E, et al. Acetaminophen, via its reactive metabolite N-Acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation, causes neurogenic inflammation in the airways and other tissues in rodents. FASEB J 2010;24:4904-16
31. de Paramo BJ, Gancedo SQ, Cuevas M, et al. Paracetamol (acetaminophen) hypersensitivity. Ann Allergy Asthma Immunol 2000;85:508-11
32. Carroll KN, Hartert TV. The impact of respiratory viral infection on wheezing illnesses and asthma exacerbations. Immunol Allergy Clin North Am 2008;28: 539-61
33. Singh M. Paracetamol as a risk factor for allergic disorders. Lancet 2009;373:119
34. Tapiainen T, Dunder T, Möttönen M, et al. Adolescents with asthma or atopic eczema have more febrile days in early childhood: A possible explanation for the connection between paracetamol and asthma? J Allergy Clin Immunol 2010;125: 751-2